Validated and peer-reviewed research
Our research is validated by a long track record of peer-reviewed publications in high-impact journals in collaboration with our industry and scientific partners.
Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
Frontiers in Immunology
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector readministration
Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance